Literature DB >> 1619424

HLA antigens in familial Guillain-Barré syndrome.

D L Davidson, A F O'Sullivan, K D Morley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1619424      PMCID： PMC1014913          DOI： 10.1136/jnnp.55.6.508

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Familial Guillain-Barré syndrome.

Authors:  G A MacGregor
Journal:  Lancet       Date:  1965-12-18       Impact factor: 79.321

2.  HLA antigens in the Guillain-Barré syndrome.

Authors:  J B Winer; D Briggs; K Welsh; R A Hughes
Journal:  J Neuroimmunol       Date:  1988-04       Impact factor: 3.478

3.  Familial Guillain-Barŕe syndrome.

Authors:  M Saunders; M Rake
Journal:  Lancet       Date:  1965-11-27       Impact factor: 79.321

4.  Electrophysiologic studies in Miller Fisher syndrome.

Authors:  G A Jamal; W N MacLeod
Journal:  Neurology       Date:  1984-05       Impact factor: 9.910

5.  HLA-DR antigens in Mexican patients with Guillain-Barré syndrome.

Authors:  C Gorodezky; B Varela; L E Castro-Escobar; A Chávez-Negrete; A Escobar-Gutiérrez; J Martínez-Mata
Journal:  J Neuroimmunol       Date:  1983-02       Impact factor: 3.478
  5 in total
  3 in total

Review 1.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

2.  Familial Guillain-Barré syndrome: First Indian report.

Authors:  Karkal Ravishankar Naik; Aralikatte Onkarappa Saroja; Basangouda P Patil
Journal:  Ann Indian Acad Neurol       Date:  2012-01       Impact factor: 1.383

3.  A report of a probable case of familial Guillain Barre syndrome.

Authors:  Mohammad Barzegar; Amir Hossein Jafari Rouhi; Mehdi Farhoudi; Sara Sardashti
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.